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restaurants. Japan consumes about 
80 per cent of Pacific and Atlantic 
bluefin tuna.
The country has been accused  
of stifling efforts to enhance 
protection of the tuna stocks. In 
negotiations last year, a bid by 
Monaco, backed by several other 
European countries, to introduce 
a ban on commercial fishing of 
Atlantic bluefin tuna failed because 
of perceived support from several 
smaller nations for Japan’s 
opposition at last year’s meeting  
of the International Commission  
for the Conservation of Atlantic 
Tunas. Although they cut fishing 
quotas, conservationists believe 
such measures do not go far  
enough, particularly in the light of 
illegal fishing becoming ever  
more lucrative as Tokyo prices soar.
The WWF has warned that, if 
fishing continues at current rates, 
the Atlantic bluefin tuna will be 
‘functionally extinct’ in three years. 
But such concerns appear to 
have little impact for Japanese 
consumers. Market officials are 
accustomed to seeing prices rise 
during the year’s opening  
auction at the Tsukiji fish market,  
but the new record was still 
unexpected.
The tuna sold last month was one of 
500 bluefin brought for the first auction 
of the year. It was caught in waters off 
the northern island of Hokkaido. Today, 
Pacific bluefin are very rare. From 
1976 to 2006, stocks fell 90 per cent 
because of increased fishing pressure, 
prompting the UN Convention on 
International Trade in Endangered 
Species (Cites) to add them to their list 
of threatened species.
“The custom of eating raw fish is 
spreading throughout the world,  
so that it is no longer an era  
where Japan is consuming all  
of the limited supply of tuna,” an 
auction manager told the Guardian. 
But Japan remains the major market. 
They go to the supermarket and are 
fooled into thinking everything is 
available in abundance, says  
Wakao Hanaoka, an ocean 
campaigner for Greenpeace  
Japan. “But it is not possible for the 
Japanese to continue to eat tuna at 
this rate.”
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What turned you on to biology in 
the first place? I know it sounds 
like a cliché, but when I was a child I 
spent lots of time outdoors, watching 
animals, catching fish, keeping various 
animals at home, and I often went 
to the public library to get all kinds 
of books about animals. My general 
interest in animals became further 
stimulated at secondary school where 
my biology teacher had created a 
small zoo, and I acted as care-taker. 
This allowed me to expand my interest 
in keeping and observing animals 
further compared with the more 
restricted Berlin apartment conditions 
I had at home. My special interest in 
amphibians brought me to Berlin’s well-
known Natural History Museum where 
I worked with the herpetology curator 
prior to university. Later I realized that 
the traditional way of taxonomy is not 
my cup of tea, and I wanted to combine 
taxonomy with molecular biology. At 
university, I switched to non-human 
primates (for my diploma thesis), and 
to humans (for my PhD thesis), keeping 
with the use of molecular genetics for 
understanding species and population 
diversity and history. The latter keeps 
driving me till today, with my scientific 
interests in human population and 
evolutionary genetics, as well as 
forensic molecular biology. But I still like 
to be out in nature, and in particular, in 
intact tropical rainforests.    
Q & A What is the best advice you’ve been given, and what advice would 
you offer? There is one phrase that 
comes to my mind from time to time: 
“It takes the same amount of time and 
effort to do a good research project 
as it takes to do a bad one, so why 
do a bad one?” Of course, it’s not 
always that simple — everyone who 
designs research projects knows that. 
If someone has identified his/her thing, 
an area he/she burns for, than my 
advice would be: “Go for it!” Passion 
is the best prerequisite to become 
good, successful and fulfilled by 
your work. But I also think that young 
people should be aware of the potential 
consequences when choosing a career 
in biology, such as the life of a scientific 
nomad or living abroad for longer 
periods of time. 
If you knew then what you know 
now, would you still pursue the 
same path?  
I probably would have, because I was 
and I still am driven by the things I am 
doing. I am privileged to have found 
my niche where I am able to do what 
I want because it interests me. During 
childhood, my passion was always split 
between biology and music. Although I 
had passed the entrance examination at 
a conservatory, I finally decided to apply 
for biology and was lucky to get in. At 
the time, this wasn’t easy in the country 
I grew up in, the German Democratic 
Republic, because there were only 
about a hundred places for biology per 
year from all the universities across 
the country. However, sometimes, for 
instance when reading those peer-
reviews that occasionally are painful,  
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What are kindlins and why are 
they getting so much attention? 
Kindlins are evolutionarily conserved, 
FERM-domain-containing adaptor 
proteins important for signaling to and 
from integrin adhesion receptors. In 
mammals, the kindlin family comprises 
kindlin-1, -2 and -3, each encoded 
by a different gene. Drosophila have 
two kindlins (fermitin-1 and -2), while 
Caenorhabditis elegans has only one 
(UNC-112). Although only recently 
identified, in the past three years there 
has been a surge of interest in kindlins, 
spurred by the finding that kindlin 
mutations trigger human disease, by 
the unique organization of the kindlin 
FERM domain and, most notably, 
by the realization that kindlins play 
essential roles in regulation of integrin 
activation. This final point is supported 
by data from knockout animals, 
disease mutations, and overexpression 
studies and is noteworthy because 
previously the only well-recognized, 
direct integrin activator was talin, 
a kindlin-related, FERM-domain-
containing, integrin-binding, adaptor 
protein. Mechanistically, how kindlins 
act remains unknown, but improved 
understanding of kindlin structure, 
function and interactions is likely to 
reveal where kindlins fit into the process 
of talin-mediated integrin activation 
and how integrin–kindlin interactions 
regulate adhesion signaling.
Where does the name come from? 
The various routes by which kindlins 
were identified are reflected in their 
alternative names. The first indication of 
a role for kindlins in integrin-mediated 
adhesion came from genetic screens 
in C. elegans, in which UNC-112 was 
identified as an essential intracellular 
protein that localizes at cell–matrix 
adhesion structures. Human kindlin-1 
and -3 were originally named UNC-112-
related proteins-1 and -2, while kindlin-2 
was cloned as mitogen-induced gene-2. 
Kindlins are also called fermitin family 
homologs, for their homology with 
Drosophila fermitins, whose name 
reflects the importance of the FERM 
domain in these proteins. However, the 
Quick guideI do wonder about an alternative to my career (or, instead, to the peer-review 
system, not sure which of the two 
would be easier). 
What is your favourite/least  
favourite conference? I was inspired 
by the Cold Spring Harbour Meetings 
on Human Evolution and Disease in 
the 1990s which brought together the 
scientific world elite from various fields 
of human evolution. Unfortunately, 
dedicated conferences that include 
specialists from different fields 
working on human evolution such as 
palaeontology, archaeology, linguistic, 
biological and cultural anthropology 
are rare. Although it is not always easy 
to find a common language between 
people of such diverse disciplines, it is 
possible. I know this from my time at the 
Max Planck Institute for Evolutionary 
Anthropology in Leipzig, where such 
an interdisciplinary approach to human 
evolution is practised with great 
success.
Do you have a ‘scientific hero’? 
I don’t really have a scientific hero. 
However, I do esteem (and prefer 
collaborating with) colleagues who 
manage to be both good scientists as 
well as good human beings (in contrast 
to the turbo-capitalists in science who are 
successful to the disadvantage of others). 
A good example for the former is Mark 
Stoneking whom I have had the privilege 
to work with for many years already and 
hopefully many more to come.
What do you think about electronic 
publishing? I think e-publishing 
is great, simply because it allows 
speedy publication, and I am actively 
supporting it as Co-Editor-in-Chief 
of the new e-journal Investigative 
Genetics. Everyone of us knows that 
desperate feeling of waiting weeks 
or months until an accepted paper 
gets finally published (and the pain 
of getting scooped at the very last 
moment). Indeed, I now prefer to look 
at papers online instead of final issues 
of journals, and almost never look at 
print issues anymore. I know some still 
prefer having a printed journal, but I 
believe that the advantage of speedy 
publication outweighs nostalgic feelings 
towards the printed page. I also value 
open-access publishing for a wider 
distribution of scientific knowledge, 
and actively support it, as an Academic 
Editor of PLoS One. However, I also see 
the advantage of having professional copy editors: they can make the life of 
an author easier, especially for us  
non-native English speakers.
What is your greatest ambition 
in science? We all know that 
genetics must play a major role in 
the determination of human facial 
appearance, because monozygotic 
twins look identical, at least for parts 
of their life. However, although we 
are constantly accumulating genetic 
knowledge for many human diseases, 
we know almost nothing yet about the 
genes determining facial appearance. 
I would like to find out — or at least 
contribute to finding out — which genes 
determine human facial morphology. 
For instance, I am co-chairing the 
international VisiGen consortium 
aiming to find genetic factors that 
determine human visible traits. To me, 
this is fascinating not only because of 
the general scientific interest but also 
because it may provide future forensic 
applications.
What do you think are the big 
questions in your field? Currently, my 
favourite question in forensic molecular 
biology is to what degree it will be 
possible to estimate human appearance 
from biological samples found at 
crime scenes. DNA-based appearance 
prediction is expected to provide 
investigative leads to find unknown 
individuals, who cannot be identified 
with current forensic DNA profiling 
techniques. At present, this is already 
feasible for some group-specific traits 
such as eye color. However, it really 
is individual-specific appearance (i.e. 
facial morphology), which would be of 
most use in the search for an unknown 
person, but where we lack almost any 
genetic insights thus far. In human 
evolutionary genetics, an exciting 
question is how humans genetically 
adapted to their environment. Some 
genes have already been identified 
that contribute to certain phenotypes 
and carry strong signatures of positive 
selection, such as those involved in 
skin color variation. However, many 
more human traits are expected to 
be determined by environmental 
interactions and it will be fascinating 
to establish genetic (and ultimately 
functional) evidence for these. 
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